Glucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial.

Y, Seino; MF, Rasmussen; T, Nishida; K, Kaku

doi:10.1111/j.2040-1124.2011.00103.x

Public

Glucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial.

Shared by NobleBlocks on Aug 1, 2011 • 12:00 AM UTC

Authors:

Seino Y

Rasmussen MF

Nishida T

Abstract

<h4>Unlabelled</h4>Aims/Introduction: Sulfonylurea (SU) agents are the most effective drugs at lowering blood glucose when used alone. However, their effectiveness declines after a certain period. The addition of liraglutide to existing SU therapy might reverse some of the known drawbacks of SU.<h4...

Subject

sulfonylurea

Liraglutide

Glucagon‐like Peptide‐1 Receptor Agonist

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!